费罗斯塔丁-1 抑制骨质细胞分化,并通过抑制脂质过氧化来预防骨质疏松症
Wenbo Xu1,2, Shiyan Lv1, Xiaoyan Wang1
1Department of Orthopedics, The Second Affiliated Hospital of Harbin Medical University, No. 246 Xuefu Road, Harbin, 150001, Heilongjiang Province, China.
Journal of orthopaedic surgery and research
|January 30, 2025
概括
铁素-1 (Fer-1) 通过减少脂质过氧化和通过p38/JNK/MAPK通路抑制骨质细胞分化来抑制骨质疏松症. 这种治疗还促进骨形成和血管生长,在体内表现出抗骨质疏松作用.
科学领域:
- 生物医学研究的研究.
- 细胞生物学 细胞生物学
- 骨质疏松症的研究研究.
背景情况:
- 骨质疏松症 (OP) 是一种全身性骨疾病,其特点是骨质较低.
- 脂质过氧化是OP研究中兴趣的一个新兴领域.
- 脂质过氧化物在骨质细胞分化中的确切作用尚不清楚.
研究的目的:
- 调查脂质过氧化在骨质细胞分化中的作用.
- 评估铁素-1 (Fer-1) 对骨质细胞形成和相关信号通路的影响.
- 在骨质疏松症的体内模型中评估Fer-1的治疗潜力.
主要方法:
- 从小鼠骨髓巨细胞 (BMM) 诱导的骨质细胞分化.
- 评估了骨质细胞形成,脂质过氧化标志物 (ROS,MDA,ACSL4,LPCAT3,GSH,GPX4) 和p38/JNK/MAPK通路的激活.
- 评估了使用BMM超级生物的骨质生成和血管生成.
- 在活体卵巢切除 (OVX) 的小鼠模型中利用了Fer-1.
主要成果:
- 脂质过氧化标志物在骨质细胞生成过程中增加; Fer-1 治疗抑制了骨质细胞的分化并降低了脂质过氧化物水平.
- 铁-1通过抑制p38/JNK/MAPK通路来抑制骨质细胞标记物.
- 在OVX小鼠中,Fer-1治疗增强了骨质生成和血管生成,并减轻了骨质疏松症.
结论:
- 铁-1通过减少脂质过氧化,通过ACSL4和p38/JNK/MAPK通路调节,抑制骨质细胞分化.
- 铁-1促进骨质生成和血管生成的合.
- 在体内,Fer-1显示出显著的抗骨质疏松作用.
相关概念视频
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
Necrosis
4.1K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.1K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
522
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
522
Bone Remodeling
38.1K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.1K
Hormones and Bone Tissue
2.6K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.6K
Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K


